The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy

被引:11
|
作者
Korakas, Emmanouil [1 ]
Ikonomidis, Ignatios [2 ]
Markakis, Konstantinos [1 ]
Raptis, Athanasios [1 ]
Dimitriadis, George [1 ]
Lambadiari, Vaia [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Med Sch, Dept Internal Med 2, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Med Sch, Cardiol Dept 2, Athens, Greece
关键词
Glycocalyx; vascular permeability; imaging; albuminuria; nephropathy; oxidative stress; diabetes; HEPARAN-SULFATE PROTEOGLYCAN; SURFACE-LAYER; GLOMERULAR-FILTRATION; CELL GLYCOCALYX; IN-VIVO; STRUCTURAL DETERMINANTS; EXTRACELLULAR-MATRIX; INDUCED DEGRADATION; CHARGE SELECTIVITY; VEGF-A;
D O I
10.2174/1570161118666191224120242
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The endothelial glycocalyx is a complex mesh of proteoglycans, glycoproteins and other soluble components, which cover the vascular endothelium. It plays an important role in many physiological processes including vascular permeability, transduction of shear stress and interaction of blood cells and other molecules with the vascular wall. Its complex structure makes its precise assessment challenging, and many different visualization techniques have been used with varying results. Diabetes, one of the main disease models where disorders of the glycocalyx are present, causes degradation of the glycocalyx through a variety of molecular pathways and especially through oxidative stress due to the action of reactive oxygen species. As the glycocalyx has been primarily studied in the glomerular endothelium, more evidence points towards a vital role in albumin handling and, consequently, in diabetic nephropathy. Therefore, the maintenance or restoration of the integrity of the glycocalyx seems a promising therapeutic target. In this review, we consider the structural and functional capacities of the endothelial glycocalyx, the available methods for its evaluation, the mechanisms through which diabetes leads to glycocalyx degradation and albuminuria, and possible treatment options targeting the glycocalyx.
引用
下载
收藏
页码:619 / 631
页数:13
相关论文
共 50 条
  • [1] Endothelial glycocalyx restoration by growth factors in diabetic nephropathy
    Desideri, Sara
    Onions, Karen L.
    Baker, Sian L.
    Gamez, Monica
    Hussien, Hesham El Hegni E.
    Russell, Amy
    Satchell, Simon C.
    Foster, Rebecca R.
    BIORHEOLOGY, 2019, 56 (2-3) : 163 - 179
  • [2] The glycocalyx, a novel key in understanding of mechanism of diabetic nephropathy: a commentary
    Behnam Amirpour-Najafabadi
    Seyed-Sirvan Hosseini
    Parnian Sam-Sani
    Erfan Rezaei
    Majid Ramezani
    Saeed Changizi-Ashtiyani
    Journal of Diabetes & Metabolic Disorders, 2021, 20 : 2049 - 2053
  • [3] The glycocalyx, a novel key in understanding of mechanism of diabetic nephropathy: a commentary
    Amirpour-Najafabadi, Behnam
    Hosseini, Seyed-Sirvan
    Sam-Sani, Parnian
    Rezaei, Erfan
    Ramezani, Majid
    Changizi-Ashtiyani, Saeed
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2021, 20 (02) : 2049 - 2053
  • [4] Reduced sublingual endothelial glycocalyx in type 1 diabetic patients with diabetic nephropathy
    Winther, S. A.
    Frimodt-Moller, M.
    Zobel, E. H.
    Hansen, T. W.
    Rossing, P.
    DIABETOLOGIA, 2017, 60 : S499 - S500
  • [5] Is Oxidized Albumin, a Mediator and a Biomarker of Systemic Inflammation in Diabetic Nephropathy?
    Michelis, Regina
    Kristal, Batya
    Shapiro, Galina
    Fridman, Yoav
    Zeitun, Teuta
    Geron, Ronit
    Sela, Shifra
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S78 - S78
  • [6] 5.2: Reduced Sublingual Endothelial Glycocalyx in Type 1 Diabetics with Diabetic Nephropathy
    Signe Abitz Winther
    Artery Research, 2017, 20 (1) : 59 - 59
  • [7] Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
    Boels, Margien G. S.
    Avramut, M. Cristina
    Koudijs, Angela
    Dane, Martijn J. C.
    Lee, Dae Hyun
    van der Vlag, Johan
    Koster, Abraham J.
    van Zonneveld, Anton Jan
    van Faassen, Ernst
    Groene, Hermann-Josef
    van den Berg, Bernard M.
    Rabelink, Ton J.
    DIABETES, 2016, 65 (08) : 2429 - 2439
  • [8] Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy
    Oltean, Sebastian
    Qiu, Yan
    Ferguson, Joanne K.
    Stevens, Megan
    Neal, Chris
    Russell, Amy
    Kaura, Amit
    Arkill, Kenton P.
    Harris, Kirstie
    Symonds, Clare
    Lacey, Katja
    Wijeyaratne, Lihini
    Gammons, Melissa
    Wylie, Emma
    Hulse, Richard P.
    Alsop, Chloe
    Cope, George
    Damodaran, Gopinath
    Betteridge, Kai B.
    Ramnath, Raina
    Satchell, Simon C.
    Foster, Rebecca R.
    Ballmer-Hofer, Kurt
    Donaldson, Lucy F.
    Barratt, Jonathan
    Baelde, Hans J.
    Harper, Steven J.
    Bates, David O.
    Salmon, Andrew H. J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (08): : 1889 - 1904
  • [9] The Loss of Endothelial Glycocalyx in Diabetic Retinopathy
    Kaur, Gaganpreet
    Song, Yuefan
    Xia, Ke
    Cruz-Topete, Diana
    McCarthy, Kevin
    Zhang, Fuming
    Linhardt, Robert
    Harris, Norman
    FASEB JOURNAL, 2022, 36
  • [10] Angiopoietin-2 is a mediator of endothelial glycocalyx digestion
    Hesse, B.
    Hillgruber, C.
    Kusche-Vihrog, K.
    Pavenstaedt, H.
    Rovas, A.
    George, T.
    Kuempers, P.
    Lukasz, A.
    ACTA PHYSIOLOGICA, 2017, 219 : 106 - 106